# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-065660
Filing Date
2025-05-07
Accepted
2025-05-07 16:10:24
Documents
69
Period of Report
2025-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | rvmd-20250331.htm iXBRL | 10-Q | 2749470
2 | EX-10.1 | rvmd-ex10_1.htm | EX-10.1 | 56294
3 | EX-31.1 | rvmd-ex31_1.htm | EX-31.1 | 17298
4 | EX-31.2 | rvmd-ex31_2.htm | EX-31.2 | 17257
5 | EX-32.1 | rvmd-ex32_1.htm | EX-32.1 | 9020
6 | EX-32.2 | rvmd-ex32_2.htm | EX-32.2 | 9010
| Complete submission text file | 0000950170-25-065660.txt |  | 10553178

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | rvmd-20250331.xsd | EX-101.SCH | 1188172
72 | EXTRACTED XBRL INSTANCE DOCUMENT | rvmd-20250331_htm.xml | XML | 2142926

Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Filer) CIK: 0001628171 (see all company filings)

EIN.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39219 | Film No.: 25921441
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)